ErlySign, the Nagpur-based biotech startup developing India’s first salivary biomarker–based screening test for early-stage ...

Let's face it, the holiday season doesn’t officially begin until that familiar shimmer of snow appears on screen and Sam the ...

In the last Fierce Pharma Asia weekly news roundup of 2025, Daiichi Sankyo scored a key FDA approval for ...

Distilling that complexity into a handful of trends has been no small task. What follows is not a definitive forecast, but ...

US drug makers are racing to plug looming 'patent cliff' revenue gaps - and increasingly they are turning to China biotechs ...

December has proven to be a period of significant acceleration for BioNxt Solutions. The development-stage biopharmaceutical firm is advancing on multiple st ...

With approximately $9.5 million in cash reserves and no debt, the Company is ready to leverage strengthened vertical integration as clinical-grade psilocybin moves into Phase IIb trialsNEW YORK, Dec.

Procter & Gamble's scale and cash flow strength contrast with Kimberly-Clark's execution-heavy recovery, shaping the upside debate in staples.

Dallas Stars forward Tyler Seguin has undergone surgery to repair the ACL in his right knee. The team announced Friday that ...

Bengalur-based space tech startup Digantara Industries has closed a $50 million Series B, as it looks to scale operations ...

Regulatory clearance of Bentrio in allergic rhinitis for Mainland ChinaNearly 200 million Chinese estimated to suffer from allergic rhinitisBentrio to be launched by partner Nuance Pharma HAMILTON, ...

The crackdown on foreign students and tougher immigration policies have made the US less welcoming, prompting many to ...